Search

everythinglearnresearchcommunity

for

Search:↓

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Overweight women with PCOS are more likely to have excess male hormones.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Spironolactone treatment increases the amount of testosterone available in the body.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.

Polycystic Ovarian Syndrome (PCOS) is a common condition causing fertility issues and other symptoms, with unclear causes and treatments focused on improving insulin sensitivity.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Different types of PCOS need specific diagnosis methods and treatments.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.